| Literature DB >> 22087842 |
Olivier Lambercy1, Ludovic Dovat, Hong Yun, Seng Kwee Wee, Christopher W K Kuah, Karen S G Chua, Roger Gassert, Theodore E Milner, Chee Leong Teo, Etienne Burdet.
Abstract
BACKGROUND: Rehabilitation of hand function is challenging, and only few studies have investigated robot-assisted rehabilitation focusing on distal joints of the upper limb. This paper investigates the feasibility of using the HapticKnob, a table-top end-effector device, for robot-assisted rehabilitation of grasping and forearm pronation/supination, two important functions for activities of daily living involving the hand, and which are often impaired in chronic stroke patients. It evaluates the effectiveness of this device for improving hand function and the transfer of improvement to arm function.Entities:
Mesh:
Year: 2011 PMID: 22087842 PMCID: PMC3280186 DOI: 10.1186/1743-0003-8-63
Source DB: PubMed Journal: J Neuroeng Rehabil ISSN: 1743-0003 Impact factor: 4.262
Demographic characteristics and stroke subtypes (N = 15)
| subject | age (years) | gender (M/F) | time post- | initial Fugl-Meyer score | stroke type | lesion site |
|---|---|---|---|---|---|---|
| A1 | 55 | M | 929 | 32 | hemorrhagic | left basal ganglia |
| A2 | 68 | M | 1064 | 34 | hemorrhagic | right basal ganglia |
| A3 | 48 | M | 323 | 13 | hemorrhagic | left basal ganglia |
| A4 | 46 | M | 679 | 34 | ischemic | right temporal, basal ganglia, corona radiata, thalamus |
| A5 | 61 | F | 458 | 43 | ischemic | right frontal-temporal, insula |
| A6 | 78 | F | 831 | 16 | ischemic | right temporal, basal ganglia |
| A7 | 63 | F | 934 | 42 | ischemic | right basal ganglia |
| A8 | 73 | F | 319 | 27 | hemorrhagic | left basal ganglia |
| A9 | 43 | F | 417 | 37 | hemorrhagic* | right frontal lobe |
| A10 | 71 | F | 318 | 40 | ischemic | right corona radiata, basal ganglia |
| A11 | 65 | F | 271 | 33 | ischemic* | right basal ganglia, corona radiata, external capsule frontal-parietal, thalamus |
| A12 | 31 | M | 297 | 35 | hemorrhagic | right parietal lobe |
| A13 | 55 | M | 480 | 14 | hemorrhagic | right basal ganglia |
| A14 | 44 | F | 627 | 41 | hemorrhagic | left basal ganglia |
| A15 | 32 | M | 1041 | 45 | hemorrhagic | right basal ganglia |
| mean | 55.5 ± 14.6 | - | 597.5 ± 294.1 | 32.4 ± 10.5 | - | - |
* recurrent stroke
all subjects were right handed
Figure 1The HapticKnob robot and the proposed therapy protocol. A: Stroke subject training on the HapticKnob. B: Visual feedback of the opening/closing (left) and pronation/supination (right) exercises, where subjects have to squeeze, respectively orient the picture into a white frame by grasping, respectively turning the HapticKnob. C: Details of therapy and session protocol.
Primary outcome measures at week 0, week 6 and week 12 for the 13 subjects that were retained for data analysis (mean ± std), and p-values of the statistical analysis (Friedman tests with 0.025 significance level and post-hoc Wilcoxon tests with 0.05 significance level).
| Primary outcome measures | week 0 | week 6 | week 12 | Friedman test | Wilcoxon test 0-6 | Wilcoxon test 0-12 |
|---|---|---|---|---|---|---|
| Fugl-Meyer total (normal = 66) | 32.15 ± 11.31 | 35.15 ± 12.05 | 37.00 ± 11.21 | 0.001 | 0.009 | 0.005 |
| Subportion wrist/hand (normal = 24) | 8.23 ± 4.38 | 9.15 ± 4.74 | 10.23 ± 5.40 | 0.002 | 0.018 | 0.009 |
| Subportion shoulder/elbow (normal = 42) | 23.92 ± 8.54 | 26.00 ± 8.81 | 26.77 ± 7.56 | 0.042 | n.a. | n.a. |
| Motricity Index (normal = 100) | 50.62 ± 15.41 | 55.16 ± 17.99 | 57.46 ± 16.26 | 0.001 | 0.025 | 0.003 |
| Subportion hand/fingers (normal = 33) | 12.46 ± 16.25 | 13.54 ± 10.84 | 14.69 ± 11.33 | 0.551 | n.a. | n.a. |
| Subportion shoulder/elbow (normal = 66) | 37.15 ± 9.94 | 40.62 ± 11.74 | 41.38 ± 11.16 | 0.002 | 0.027 | 0.011 |
Figure 2Results of the Fugl-Meyer scores for the upper extremity. Comparison of Fugl-Meyer (FM) scores for the upper extremity between week0/week6, and week0/week12. Circles represent results of the 13 participants included in the data analysis, squares represent the mean over the 13 subjects, and crosses represent results of subjects A11 and A12, who had a break in the treatment and were thus excluded from the analysis. Dashed lines illustrate a 3-point improvement on the FM considered as a functionally meaningful improvement [10].
Figure 3Primary outcome measures. Evolution of Fugl-Meyer (FM) scores for the upper extremity and Motricity Index (MI) scores for the 13 subjects that were retained for data analysis (mean ± std), with details of sections related to the lower and upper arm (*p < 0.05).
Secondary outcome measures at week 0, week 6 and week 12 for the 13 subjects that were retained for data analysis (mean ± std), and p-values of the statistical analysis (Friedman tests with 0.05 significance level and post-hoc Wilcoxon tests with 0.05 significance level).
| Secondary outcome measures | week 0 | week 6 | week 12 | Friedman test | Wilcoxon test 0-6 | Wilcoxon test 0-12 |
|---|---|---|---|---|---|---|
| Motor Assessment Scale (normal = 18) | 4.08 ± 3.30 | 5.08 ± 3.30 | 5.23 ± 3.63 | 0.004 | 0.010 | 0.006 |
| Modified Ashworth Scale (normal = 0) | 8.31 ± 3.12 | 7.38 ± 2.43 | 7.08 ± 3.15 | 0.038 | 0.118 | 0.019 |
| Functional Test of Hemiparetic Upper Extremity (normal = 7) | 2.92 ± 0.64 | 3.08 ± 0.64 | 3.08 ± 0.64 | 0.497 | n.a. | n.a. |
| Nine Hole Peg Test * | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. |
| Grip force (impaired hand/unimpaired hand) [%] † | 21.92 ± 15.26 | 24.60 ± 12.94 | 22.02 ± 9.11 | 0.307 | n.a. | n.a. |
| Pain (Visual Analog Scale) | 0.46 ± 1.39 | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.135 | n.a. | n.a. |
| Satisfaction grade | 3.08 ± 0.76 |
* 12 subjects were unable to perform the NHPT
† 2 subjects were unable to perform grip force measurements with their impaired hand
Figure 4Example of robotic data collected by the HapticKnob. Evolution of pronation movements for patient A3 over the course of the therapy at sessions 1, 4, 8, 12, 16 and 18, each line representing one trial. The target angular position window is represented by horizontal dashed lines. Details of parameters extracted from the kinematic data are given in the lower left plot for one successful trial; tr is the time required to reach the target window for the first time, and ta is the time required to finely adjust the forearm position.
Robotic outcome measures at week 0 and week 6 for the 13 subjects that were retained for data analysis (mean ± std), and p-values of the statistical analysis (Wilcoxon tests with 0.05 significance level).
| Robotic measures | week 0 (session 1) | week 6 (session 18) | Wilcoxon test |
|---|---|---|---|
| εp [mm] | 3.03 ± 2.45 | 1.52 ± 1.21 | 0.001 |
| n0 [1/s] | 6.06 ± 0.52 | 5.75 ± 0.47 | 0.033 |
| tr [s] | 7.40 ± 3.63 | 4.67 ± 3.24 | 0.001 |
| ta [s] | 7.44 ± 3.23 | 5.24 ± 3.32 | 0.001 |